Last month, Captain Capitalism said that Human Genome Sciences Inc. (HGSI) would be a good investment.
Maybe not. Their new lupus drug missed its primary goal in a mid-stage study and the market reacted badly. As of this posting, HGSI was down 34% on the day. Ouch.
1 comment:
At least you are honest about it.
Post a Comment